image_alt_text
9

Andrew J. Geall, Ph.D.

AIMBE College of Fellows Class of 2024
For outstanding contributions to and leadership in the field of nucleic acid delivery and the development of mRNA vaccines.

Andrew Geall Inducted into the 2024 Class of the AIMBE College of Fellows

Via AIMBE | March 27, 2024

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Andrew J. Geall, Ph.D., Co-founder and Chief Development Officer at Replicate Bioscience to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”

Dr. Geall was nominated, reviewed, and elected by peers and members of the College of Fellows “for outstanding contributions to and leadership in the field of nucleic acid delivery and the development of mRNA vaccines…. Continue reading.

...